Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Septerna, Inc.
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
May 25, 2026
Septerna to Present at Bank of America Securities Health Care Conference
May 24, 2026
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
May 21, 2026
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
May 18, 2026